arrow
I

Ivan King

Sarah Cannon Research Institute
H指数:20
被引数:2,050

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors

I期研究:评估Zavondemstat(TACH101),一种首创KDM4抑制剂的疗效,用于治疗晚期实体瘤患者

2025-07-010
OAAI
Inhibitors of farnesyl protein transferase.: 4-amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine
1998-02-1934
PREAI
Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidine inhibitors of farnesyl-protein transferase:: Design and synthesis of in vivo active antitumor compounds
1997-12-1958
PREAI